Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-9.59 Insider Own3.00% Shs Outstand35.03M Perf Week-1.51%
Market Cap399.34M Forward P/E- EPS next Y-1.72 Insider Trans114.95% Shs Float33.40M Perf Month-6.02%
Income-328.30M PEG- EPS next Q-0.68 Inst Own- Short Float42.66% Perf Quarter31.79%
Sales364.30M P/S1.10 EPS this Y22.80% Inst Trans13.10% Short Ratio12.38 Perf Half Y-9.31%
Book/sh14.78 P/B0.77 EPS next Y44.70% ROA-20.90% Target Price11.67 Perf Year-49.22%
Cash/sh7.45 P/C1.53 EPS next 5Y- ROE-35.70% 52W Range6.81 - 23.77 Perf YTD-24.95%
Dividend- P/FCF- EPS past 5Y-61.90% ROI-11.90% 52W High-52.04% Beta0.37
Dividend %- Quick Ratio1.50 Sales past 5Y42.40% Gross Margin67.60% 52W Low67.40% ATR0.65
Employees467 Current Ratio1.60 Sales Q/Q-46.60% Oper. Margin-84.50% RSI (14)47.54 Volatility5.40% 5.65%
OptionableYes Debt/Eq0.54 EPS Q/Q-375.60% Profit Margin-64.30% Rel Volume0.80 Prev Close10.84
ShortableYes LT Debt/Eq0.54 EarningsNov 06 BMO Payout- Avg Volume1.15M Price11.40
Recom2.90 SMA20-3.57% SMA500.28% SMA200-5.22% Volume919,297 Change5.17%
Aug-01-19Initiated H.C. Wainwright Buy $16
Jun-11-19Initiated Barclays Overweight $19
Mar-20-19Initiated SunTrust Hold
Dec-14-18Reiterated B. Riley FBR Buy $29 → $20.50
Nov-06-18Downgrade JP Morgan Neutral → Underweight
Jun-15-18Downgrade Janney Buy → Neutral
May-21-18Resumed Leerink Partners Mkt Perform
Mar-14-18Reiterated B. Riley FBR, Inc. Neutral $16 → $23
Feb-15-18Upgrade Janney Neutral → Buy
Dec-07-17Initiated B. Riley FBR, Inc. Neutral $16
Oct-23-17Initiated Piper Jaffray Neutral $18
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
Nov-19-15Reiterated Deutsche Bank Hold $50 → $43
Oct-11-19 08:00AM  AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi (Bremelanotide Injection) Data in Obstetrics & Gynecology GlobeNewswire
Oct-08-19 08:45AM  UPDATE 2-Amag settles with activist Caligan, adds two board directors Reuters
08:14AM  Amag appoints activist investor Caligan's nominees to board Reuters
08:00AM  AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP GlobeNewswire
Sep-28-19 09:05AM  Here's Why AMAG Pharmaceuticals (NASDAQ:AMAG) Can Afford Some Debt Simply Wall St.
Sep-26-19 08:00AM  Caligan Partners Issues Letter to AMAG Shareholders Business Wire -5.42%
Sep-25-19 08:00AM  AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-23-19 08:00AM  AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders GlobeNewswire
Sep-20-19 08:44AM  UPDATE 2-Camber Capital to discuss Amag's board composition with shareholders Reuters +8.54%
08:20AM  Camber Capital says Amag Pharma's shares undervalued, seeks changes Reuters
Sep-16-19 08:00AM  Caligan Partners Launches Consent Solicitation Process and Sends Letter to AMAG Shareholders Business Wire
Sep-12-19 08:00AM  AMAG Sends Letter to Shareholders GlobeNewswire
Sep-06-19 09:31AM  Why Is AMAG Pharmaceuticals (AMAG) Up 27.3% Since Last Earnings Report? Zacks
Sep-05-19 06:24AM  Activist investor pushes for ex-Goop CEO, others to join board of Waltham drugmaker Amag American City Business Journals
Sep-04-19 05:56PM  AMAG Urges Stockholders to Take No Action on Caligan Partners Consent Solicitation Materials GlobeNewswire +8.19%
09:45AM  Activist Investor Seek Four Board Seats at Amag Pharmaceuticals Bloomberg
Aug-30-19 09:29PM  Edited Transcript of AMAG earnings conference call or presentation 7-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-27-19 08:00AM  AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi (Bremelanotide Injection) GlobeNewswire
Aug-20-19 08:00AM  AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-16-19 10:42AM  Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Zacks
06:20AM  Gene therapies to test FDA's approach to regulating drugs after launch, experts say American City Business Journals
Aug-15-19 02:23PM  [video]New York Investment Firm Discloses 10.3% Amag Stake, May Propose Changes TheStreet.com -6.25%
Aug-14-19 01:39PM  Have Insiders Been Buying AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shares? Simply Wall St.
Aug-13-19 11:42AM  Jim Cramer Shares His Thoughts On Delta Air Lines, Okta And More Benzinga
08:00AM  AMAG PHARMACEUTICALS ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4) GlobeNewswire
Aug-12-19 04:00PM  Why AMAG Pharmaceuticals Stock Jumped Today Motley Fool +14.19%
Aug-09-19 09:41AM  AMAG Pharmaceuticals Inc (AMAG) Q2 2019 Earnings Call Transcript Motley Fool +11.52%
Aug-08-19 11:20AM  AMAG Q2 Loss Widens, Sales Lag Estimates, 2019 Guidance Cut Zacks +5.09%
Aug-07-19 03:00PM  What's Behind AMAG Pharmaceuticals' Horrible Q2 Results Motley Fool -9.05%
08:35AM  AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:00AM  AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-06-19 12:50PM  UPDATE 1-Amag's female libido injectable therapy to sell at $899 Reuters +9.21%
12:43PM  Amag's female libido injectable therapy to sell at $899 Reuters
12:21PM  Amag's female libido injectable therapy to sell at $899 Reuters
Jul-31-19 10:36AM  AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-29-19 08:00AM  AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET GlobeNewswire
Jul-25-19 10:33AM  Will AMAG Pharmaceuticals (AMAG) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-23-19 09:29AM  AMAG (AMAG) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-09-19 03:07PM  Calculating The Intrinsic Value Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Simply Wall St.
Jul-04-19 08:35AM  Alexion's Ultomiris Receives EU Approval for PNH in Adults Zacks
Jun-28-19 01:03PM  Largest Insider Trades of the Week GuruFocus.com
Jun-27-19 12:55PM  Heres What Hedge Funds Think About AMAG Pharmaceuticals, Inc. (AMAG) Insider Monkey
Jun-26-19 08:37AM  Biotech Stock Roundup: Vertex, AMAG Drugs Get FDA Nod, Conatus Study Fails & More Zacks
Jun-25-19 03:49PM  Why Palatin Technologies Stock Dropped as Much as 21.5% Today Motley Fool
02:00PM  How Raleigh's Sprout can benefit from FDA's approval of another female sexual disorder drug American City Business Journals
Jun-24-19 05:45PM  AMAG's Vyleesi Gets FDA NOD for Women with Low Sexual Desire Zacks
04:19PM  Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women TheStreet.com
01:58PM  Another Womens Libido Drug, Vyleesi, Won FDA Approval. Stock Investors Arent Happy. Barrons.com
08:03AM  Palatin's stock rockets after FDA OK to market sexual desire disorder treatment MarketWatch
Jun-22-19 03:07PM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs Benzinga
Jun-21-19 05:41PM  AMAG stock rallies on FDA approval for drug to increase women's sex drive MarketWatch
05:37PM  Amags plan to bypass female libido drug pitfalls? Social media. American City Business Journals
05:23PM  AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women GlobeNewswire
Jun-20-19 09:00AM  All You Need to Know About AMAG Pharmaceuticals (AMAG) Rating Upgrade to Buy Zacks
Jun-10-19 09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
Jun-06-19 09:31AM  AMAG Pharmaceuticals (AMAG) Down 8.9% Since Last Earnings Report: Can It Rebound? Zacks
Jun-05-19 03:45PM  AMAG Pharmaceuticals Could Be Cut in Half Even From Here - Avoid TheStreet.com
May-29-19 08:00AM  AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-20-19 03:15PM  Is AMAG Pharmaceuticals, Inc.'s (NASDAQ:AMAG) Balance Sheet A Threat To Its Future? Simply Wall St.
05:21AM  New Strong Sell Stocks for May 20th Zacks
May-17-19 08:00AM  AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York GlobeNewswire
May-13-19 09:07PM  Edited Transcript of AMAG earnings conference call or presentation 7-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-10-19 10:31AM  New Strong Sell Stocks for May 10th Zacks
May-09-19 07:48PM  Is AMAG Pharmaceuticals, Inc. (AMAG) A Good Stock To Buy? Insider Monkey
07:15PM  Amag Pharmaceuticals Inc (AMAG) President & CEO William K Heiden Bought $107,000 of Shares GuruFocus.com
06:57AM  AMAG Q1 Loss Wider Than Expected, Revenues Lag Estimates Zacks
May-08-19 07:53AM  The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split Benzinga +5.56%
May-07-19 01:23PM  AMAG Pharmaceuticals Inc (AMAG) Q1 2019 Earnings Call Transcript Motley Fool -12.28%
08:35AM  AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Lags Revenue Estimates Zacks
07:28AM  AMAG Pharmaceuticals: 1Q Earnings Snapshot Associated Press
07:00AM  AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
May-03-19 08:00AM  AMAG Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual Meeting GlobeNewswire
Apr-30-19 08:05AM  AMAG Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019 at 8:00 a.m. ET GlobeNewswire
08:00AM  AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Apr-25-19 10:34AM  AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-16-19 08:00AM  AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations GlobeNewswire
Apr-12-19 09:01AM  The AMAG Pharmaceuticals (NASDAQ:AMAG) Share Price Is Down 51% So Some Shareholders Are Wishing They Sold Simply Wall St.
08:00AM  AMAG Pharmaceuticals Appoints New Members to Board of Directors GlobeNewswire
Apr-02-19 08:00AM  AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference GlobeNewswire
Mar-20-19 08:00AM  March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program GlobeNewswire
Mar-18-19 12:43PM  New Doubt on Treatment to Prevent Preterm Birth The Wall Street Journal
Mar-13-19 10:46AM  Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News Zacks
Mar-11-19 10:35AM  AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study Zacks +12.93%
Mar-09-19 09:31AM  Why Is AMAG Pharmaceuticals (AMAG) Down 24.5% Since Last Earnings Report? Zacks
Mar-08-19 11:26AM  Amag's shares fall after $323M pregnancy drug fails in post-approval trial American City Business Journals -17.71%
09:00AM  AMAG Pharmaceuticals stock down 6% after latest trial of Makena fails to meet primary endpoints MarketWatch
08:00AM  AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena® (hydroxyprogesterone caproate injection) GlobeNewswire
Mar-07-19 08:00AM  AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting GlobeNewswire
Mar-05-19 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Mar-01-19 03:48PM  AMAG Pharmaceuticals Inc (AMAG) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-28-19 12:31PM  Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-19-19 08:00AM  AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference GlobeNewswire
Feb-09-19 03:10PM  Edited Transcript of AMAG earnings conference call or presentation 7-Feb-19 1:00pm GMT Thomson Reuters StreetEvents
Feb-08-19 08:59PM  AMAG Pharmaceuticals (AMAG) Q4 2018 Earnings Conference Call Transcript Motley Fool
10:00AM  AMAG Q4 Loss Narrower Than Expected, Revenues Lag Estimates Zacks
Feb-07-19 08:55AM  AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Misses Revenue Estimates Zacks -7.60%
07:57AM  AMAG Pharmaceuticals: 4Q Earnings Snapshot Associated Press
07:00AM  AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update GlobeNewswire
Jan-30-19 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET GlobeNewswire
Jan-17-19 08:00AM  AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals GlobeNewswire
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, anemia management, and cancer supportive care in the United States. It markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company's products candidates include Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women; AMAG-423, a polyclonal antibody in development for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent for the treatment of oral anticoagulants or low molecular weight heparin. It sells Feraheme to authorized wholesalers and specialty distributors. The company has a license agreement with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio LLC, Perosphere Pharmaceuticals Inc., Antares Pharma, Inc., and Abeona Therapeutics, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Camber Capital Management LP10% OwnerAug 09Buy8.9730,000268,9964,390,000Aug 09 03:41 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 07Buy7.4340,000297,200240,000Aug 09 05:05 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 07Buy7.32260,0001,903,2004,060,000Aug 09 05:05 PM
Camber Capital Management LP10% OwnerAug 07Buy7.78355,0002,760,7964,360,000Aug 09 03:41 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy9.4720,000189,400200,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy9.5244,000418,8803,800,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 26Buy9.13120,0001,095,6003,756,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 25Buy8.8655,000487,050180,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 25Buy8.59259,0162,224,9473,636,000Jun 27 06:29 PM
Krop JulieChief Medical OfficerMay 28Buy9.9110,00099,10081,399May 29 04:27 PM
HEIDEN WILLIAM KPresident & CEOMay 09Buy10.7010,000107,000490,056May 09 04:16 PM
Bolgiano Elizabeth ScottChief Human Resources OfficerMay 09Buy10.935,00054,65074,847May 09 04:14 PM
Vittiglio JosephEVP, General CounselMar 07Sale14.011,42519,96478,955Mar 11 04:41 PM